Your browser doesn't support javascript.
loading
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial.
Ristau, J; Hörner-Rieber, J; Buchele, C; Klüter, S; Jäkel, C; Baumann, L; Andratschke, N; Garcia Schüler, H; Guckenberger, M; Li, M; Niyazi, M; Belka, C; Herfarth, K; Debus, J; Koerber, S A.
Afiliação
  • Ristau J; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. jonas.ristau@med.uni-heidelberg.de.
  • Hörner-Rieber J; Heidelberg Institute of Radiation Oncology (HIRO), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany. jonas.ristau@med.uni-heidelberg.de.
  • Buchele C; National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany. jonas.ristau@med.uni-heidelberg.de.
  • Klüter S; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
  • Jäkel C; Heidelberg Institute of Radiation Oncology (HIRO), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Baumann L; National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany.
  • Andratschke N; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Garcia Schüler H; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
  • Guckenberger M; Heidelberg Institute of Radiation Oncology (HIRO), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Li M; National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany.
  • Niyazi M; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
  • Belka C; Heidelberg Institute of Radiation Oncology (HIRO), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Herfarth K; National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany.
  • Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
  • Koerber SA; Heidelberg Institute of Radiation Oncology (HIRO), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Radiat Oncol ; 17(1): 75, 2022 Apr 15.
Article em En | MEDLINE | ID: mdl-35428327

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Radiocirurgia Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Qualitative_research / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Radiocirurgia Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Qualitative_research / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article